IGM Biosciences (IGMS) Insider Trading & Ownership $1.74 +0.03 (+1.70%) As of 12:07 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends IGM Biosciences (NASDAQ:IGMS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage57.00%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$3.17 MNumber OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$426,814.94 Get IGMS Insider Trade Alerts Want to know when executives and insiders are buying or selling IGM Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address IGMS Insider Buying and Selling by Quarter IGM Biosciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/15/2025Steven WeberInsiderSell1,122$1.70$1,907.40 12/16/2024Mary Beth HarlerCEOSell1,708$7.48$12,775.84 12/16/2024Steven WeberInsiderSell539$7.48$4,031.72 9/13/2024Fred SchwarzerCEOSell3,946$11.54$45,536.84 9/13/2024Misbah TahirCFOSell1,487$11.54$17,159.98 9/13/2024Steven WeberInsiderSell469$11.54$5,412.26 7/25/2024Julie HambletonDirectorSell15,132$14.00$211,848.00 6/14/2024Fred SchwarzerCEOSell4,164$7.58$31,563.12 6/14/2024Misbah TahirCFOSell1,570$7.58$11,900.60 6/14/2024Steven WeberInsiderSell495$7.58$3,752.10 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 3/28/2024Bros. Advisors Lp BakerDirectorBuy97,473$9.62$937,690.26 3/26/2024Bros. Advisors Lp BakerDirectorBuy270,000$8.26$2,230,200.00 3/13/2024Fred SchwarzerCEOSell4,765$9.88$47,078.20 3/13/2024Misbah TahirCFOSell2,897$9.88$28,622.36 3/13/2024Steven WeberInsiderSell529$9.88$5,226.52 (Data available from 1/1/2013 forward) IGMS Insider Trading Activity - Frequently Asked Questions Who is on IGM Biosciences's Insider Roster? The list of insiders at IGM Biosciences includes Bros. Advisors Lp Baker, Bruce Keyt, Chris H Takimoto, Fred Schwarzer, George Gauthier, Jakob Haldor Topsoe, Julie Hambleton, M Kathleen Behrens, Mary Beth Harler, Michael D Loberg, Misbah Tahir, and Steven Weber. Learn more on insiders at IGMS. What percentage of IGM Biosciences stock is owned by insiders? 57.00% of IGM Biosciences stock is owned by insiders. Learn more on IGMS's insider holdings. Which IGM Biosciences insiders have been buying company stock? The following insiders have purchased IGMS shares in the last 24 months: Bros. Advisors Lp Baker ($5,574,739.47), Jakob Haldor Topsoe ($31,850.00), and M Kathleen Behrens ($900,000.00). How much insider buying is happening at IGM Biosciences? Insiders have purchased a total of 858,796 IGMS shares in the last 24 months for a total of $6,506,589.47 bought. Which IGM Biosciences insiders have been selling company stock? The following insiders have sold IGMS shares in the last 24 months: Bruce Keyt ($48,498.70), Chris H Takimoto ($55,940.73), Fred Schwarzer ($225,767.44), George Gauthier ($28,031.37), Julie Hambleton ($211,848.00), Mary Beth Harler ($12,775.84), Misbah Tahir ($64,448.16), and Steven Weber ($20,330.00). How much insider selling is happening at IGM Biosciences? Insiders have sold a total of 73,256 IGM Biosciences shares in the last 24 months for a total of $667,640.24 sold. IGM Biosciences Key ExecutivesMr. Fred M. Schwarzer J.D. (Age 71)CEO, President & Director Compensation: $977.66kDr. Bruce A. Keyt Ph.D. (Age 70)Chief Scientific Officer Compensation: $692.95kDr. Chris H. Takimoto FACP (Age 65)M.D., Ph.D., Chief Medical Officer Compensation: $684.95kMr. Misbah Tahir (Age 48)Chief Financial Officer Compensation: $957.6k1 recent tradesMr. TS HarigopalSenior Vice President of Group OperationsMr. Steven Weber (Age 48)Senior VP, Corporate Controller & Principal Accounting Officer 3 recent tradesMr. Paul C. GraffagninoSenior Vice President of Legal AffairsMs. Suzette Tauber (Age 60)Chief Human Resources Officer Dr. Angus M. Sinclair Ph.D.Senior Vice President of Immuno-OncologyDr. Lisa L. Decker Ph.D. (Age 54)Chief Business Officer Compensation: $528.18k More Insider Trading Tools from MarketBeat Related Companies ORGO Insider Selling KALV Insider Selling AURA Insider Selling RVNC Insider Selling ALLO Insider Selling PRME Insider Selling KOD Insider Selling TERN Insider Selling ETON Insider Selling CYRX Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys3 Stocks That Wall Street Insiders Can’t Stop Buying This page (NASDAQ:IGMS) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IGM Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IGM Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
